Bibevski Steven, Levy Alexandra, Scholl Frank G
Section of Pediatric and Congenital Cardiac Surgery, The Heart Institute, Joe DiMaggio Children's Hospital, Hollywood, Florida.
Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, Institut Thoracique d'Oncologie (IOT), Villejuif, France.
Interact Cardiovasc Thorac Surg. 2017 Apr 1;24(4):639-640. doi: 10.1093/icvts/ivw406.
We recently reported the feasibility of a handmade left atrioventricular valve using decellularized extracellular matrix for 3 months in a failed repair of AV canal defect. We present the use of an extracellular matrix mitral valve for 9 months in an infant with an un-repairable congenitally malformed valve. The valve functioned perfectly without anticoagulation until the patient expired from non-cardiac complications of their fibrillin gene defect. This report adds further experience using valves made from extracellular matrix in the systemic ventricle both in terms of application and in terms of short-term durability of the construct.
我们最近报道了在房室管缺损修复失败的病例中,使用脱细胞细胞外基质制作的手工左房室瓣可行3个月。我们在此展示了在一名患有不可修复的先天性畸形瓣膜的婴儿中,使用细胞外基质二尖瓣9个月的情况。该瓣膜在未进行抗凝的情况下功能完美,直至患者因原纤维蛋白基因缺陷的非心脏并发症死亡。本报告在应用及构建物的短期耐久性方面,增加了在体心室中使用由细胞外基质制成的瓣膜的更多经验。